# PeptideScanner evidence objects: Aviptadil

Every published version of the records placed with Aviptadil, one section per evidence object. The section anchor is the object's path id; the JSON twin is https://peptidescanner.com/evidence/v1/peptides/aviptadil.json. Selected public evidence only; not medical advice.

- Objects: 9
- Manifest: https://peptidescanner.com/evidence/v1/manifest.json

---

<a id="clinicaltrials-gov-nct04843761-aviptadil-v1"></a>

## ClinicalTrials.gov record NCT04843761

> PeptideScanner retained ClinicalTrials.gov record NCT04843761 at 2026-11-16T01:46:32.736Z. Its registry update date was 2025-10-24, and PeptideScanner's reviewed identity mapping was aviptadil.

- Evidence object: `story:clinicaltrials-gov-nct04843761-aviptadil:v1`
- Evidence domain: Clinical trials
- Date in source: 2025-10-24
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct04843761-aviptadil/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/aviptadil.json#clinicaltrials-gov-nct04843761-aviptadil-v1
- Content SHA-256: `9b26a69477cbc61bd95f6cd30f5acb19d8bd5204ad20a58ec0a062111814e5c0`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT04843761 ([`ctg-observation-nct04843761-2025-10-24-498f0fee5198`](#source-ctg-observation-nct04843761-2025-10-24-498f0fee5198))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT04843761 at 2026-11-16T01:46:32.736Z. Its registry update date was 2025-10-24, and PeptideScanner's reviewed identity mapping was aviptadil. ([`ctg-observation-nct04843761-2025-10-24-498f0fee5198`](#source-ctg-observation-nct04843761-2025-10-24-498f0fee5198))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT04843761 at 2026-11-16T01:46:32.736Z. Its registry update date was 2025-10-24, and PeptideScanner's reviewed identity mapping was aviptadil. ([`ctg-observation-nct04843761-2025-10-24-498f0fee5198`](#source-ctg-observation-nct04843761-2025-10-24-498f0fee5198))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct04843761-2025-10-24-498f0fee5198`](#source-ctg-observation-nct04843761-2025-10-24-498f0fee5198))

### Sources

<a id="source-ctg-observation-nct04843761-2025-10-24-498f0fee5198"></a>
- **ClinicalTrials.gov record NCT04843761 · retained source version 2025-10-24:498f0fee5198e31733ee7b2afda3addf993427b30558424653de2ccc3a35b1d9** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT04843761) (`ctg-observation-nct04843761-2025-10-24-498f0fee5198`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT04843761." Version 1, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/aviptadil.json#clinicaltrials-gov-nct04843761-aviptadil-v1 SHA-256: 9b26a69477cbc61bd95f6cd30f5acb19d8bd5204ad20a58ec0a062111814e5c0.

---

<a id="clinicaltrials-gov-nct06729606-aviptadil-v1"></a>

## ClinicalTrials.gov record NCT06729606

> PeptideScanner retained ClinicalTrials.gov record NCT06729606 at 2026-11-16T01:46:32.736Z. Its registry update date was 2025-10-09, and PeptideScanner's reviewed identity mapping was aviptadil.

- Evidence object: `story:clinicaltrials-gov-nct06729606-aviptadil:v1`
- Evidence domain: Clinical trials
- Date in source: 2025-10-09
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct06729606-aviptadil/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/aviptadil.json#clinicaltrials-gov-nct06729606-aviptadil-v1
- Content SHA-256: `ab1cab3013e8d7fa8d9cbc779967ffd1818888cf8cd2072ed7179a181e31bc98`

### Claims and source pins

#### Headline

ClinicalTrials.gov record NCT06729606 ([`ctg-observation-nct06729606-2025-10-09-339ec06a5af5`](#source-ctg-observation-nct06729606-2025-10-09-339ec06a5af5))

#### Summary

PeptideScanner retained ClinicalTrials.gov record NCT06729606 at 2026-11-16T01:46:32.736Z. Its registry update date was 2025-10-09, and PeptideScanner's reviewed identity mapping was aviptadil. ([`ctg-observation-nct06729606-2025-10-09-339ec06a5af5`](#source-ctg-observation-nct06729606-2025-10-09-339ec06a5af5))

#### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT06729606 at 2026-11-16T01:46:32.736Z. Its registry update date was 2025-10-09, and PeptideScanner's reviewed identity mapping was aviptadil. ([`ctg-observation-nct06729606-2025-10-09-339ec06a5af5`](#source-ctg-observation-nct06729606-2025-10-09-339ec06a5af5))

#### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct06729606-2025-10-09-339ec06a5af5`](#source-ctg-observation-nct06729606-2025-10-09-339ec06a5af5))

### Sources

<a id="source-ctg-observation-nct06729606-2025-10-09-339ec06a5af5"></a>
- **ClinicalTrials.gov record NCT06729606 · retained source version 2025-10-09:339ec06a5af5887227465781f32e0b6ebc00bd09fc8552fb166e1f35a6cc4cb2** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT06729606) (`ctg-observation-nct06729606-2025-10-09-339ec06a5af5`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT06729606." Version 1, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/aviptadil.json#clinicaltrials-gov-nct06729606-aviptadil-v1 SHA-256: ab1cab3013e8d7fa8d9cbc779967ffd1818888cf8cd2072ed7179a181e31bc98.

---

<a id="pubmed-pmid-11566015-aviptadil-v1"></a>

## Aviptadil (Senatek).

> PubMed lists PMID 11566015 in Current opinion in investigational drugs (London, England : 2000) as Journal Article, Review, with publication-date metadata of 2001-04 (month precision). PeptideScanner associated the retained record with the identity slug aviptadil. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-11566015-aviptadil:v1`
- Evidence domain: Literature metadata
- Date in source: 2019-01-01
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-11566015-aviptadil/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/aviptadil.json#pubmed-pmid-11566015-aviptadil-v1
- Content SHA-256: `4e0b593be152e8cfc17b5523d36cb7e23b5906c7a20274d337cb3395ac72fe50`

### Claims and source pins

#### Headline

Aviptadil (Senatek). ([`pubmed-observation-pmid-11566015-2019-01-01-8b956b7f3b1d`](#source-pubmed-observation-pmid-11566015-2019-01-01-8b956b7f3b1d))

#### Summary

PubMed lists PMID 11566015 in Current opinion in investigational drugs (London, England : 2000) as Journal Article, Review, with publication-date metadata of 2001-04 (month precision). PeptideScanner associated the retained record with the identity slug aviptadil. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-11566015-2019-01-01-8b956b7f3b1d`](#source-pubmed-observation-pmid-11566015-2019-01-01-8b956b7f3b1d))

#### Paragraph 1

PubMed lists PMID 11566015 in Current opinion in investigational drugs (London, England : 2000) as Journal Article, Review, with publication-date metadata of 2001-04 (month precision). PeptideScanner associated the retained record with the identity slug aviptadil. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-11566015-2019-01-01-8b956b7f3b1d`](#source-pubmed-observation-pmid-11566015-2019-01-01-8b956b7f3b1d))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-11566015-2019-01-01-8b956b7f3b1d`](#source-pubmed-observation-pmid-11566015-2019-01-01-8b956b7f3b1d))

### Sources

<a id="source-pubmed-observation-pmid-11566015-2019-01-01-8b956b7f3b1d"></a>
- **Aviptadil (Senatek). · retained source version 1:2019-01-01:current:8b956b7f3b1df037057a0d0554630ae2818c682c74ca77efd904a37ba38fe6ac** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/11566015/) (`pubmed-observation-pmid-11566015-2019-01-01-8b956b7f3b1d`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Aviptadil (Senatek)." Version 1, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/aviptadil.json#pubmed-pmid-11566015-aviptadil-v1 SHA-256: 4e0b593be152e8cfc17b5523d36cb7e23b5906c7a20274d337cb3395ac72fe50.

---

<a id="pubmed-pmid-24176753-aviptadil-v1"></a>

## Analytics of the therapeutic peptide aviptadil by sheathless CE-MS and comparison with nanoRP-HPLC-MS.

> PubMed lists PMID 24176753 in Journal of pharmaceutical and biomedical analysis as Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2013-10-05 (day precision). PeptideScanner associated the retained record with the identity slug aviptadil. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-24176753-aviptadil:v1`
- Evidence domain: Literature metadata
- Date in source: 2019-01-01
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-24176753-aviptadil/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/aviptadil.json#pubmed-pmid-24176753-aviptadil-v1
- Content SHA-256: `863f561a56939a504dda9355b3a35efd900358b595680035323fb74547902503`

### Claims and source pins

#### Headline

Analytics of the therapeutic peptide aviptadil by sheathless CE-MS and comparison with nanoRP-HPLC-MS. ([`pubmed-observation-pmid-24176753-2019-01-01-9c7954565528`](#source-pubmed-observation-pmid-24176753-2019-01-01-9c7954565528))

#### Summary

PubMed lists PMID 24176753 in Journal of pharmaceutical and biomedical analysis as Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2013-10-05 (day precision). PeptideScanner associated the retained record with the identity slug aviptadil. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-24176753-2019-01-01-9c7954565528`](#source-pubmed-observation-pmid-24176753-2019-01-01-9c7954565528))

#### Paragraph 1

PubMed lists PMID 24176753 in Journal of pharmaceutical and biomedical analysis as Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2013-10-05 (day precision). PeptideScanner associated the retained record with the identity slug aviptadil. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-24176753-2019-01-01-9c7954565528`](#source-pubmed-observation-pmid-24176753-2019-01-01-9c7954565528))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-24176753-2019-01-01-9c7954565528`](#source-pubmed-observation-pmid-24176753-2019-01-01-9c7954565528))

### Sources

<a id="source-pubmed-observation-pmid-24176753-2019-01-01-9c7954565528"></a>
- **Analytics of the therapeutic peptide aviptadil by sheathless CE-MS and comparison with nanoRP-HPLC-MS. · retained source version 1:2019-01-01:current:9c7954565528f5cd54d783227b3285784432497a7d4c4e44f4d6e004a90cc8b4** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/24176753/) (`pubmed-observation-pmid-24176753-2019-01-01-9c7954565528`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Analytics of the therapeutic peptide aviptadil by sheathless CE-MS and comparison with nanoRP-HPLC-MS." Version 1, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/aviptadil.json#pubmed-pmid-24176753-aviptadil-v1 SHA-256: 863f561a56939a504dda9355b3a35efd900358b595680035323fb74547902503.

---

<a id="pubmed-pmid-34846667-aviptadil-v1"></a>

## Anticipated pharmacological role of Aviptadil on COVID-19.

> PubMed lists PMID 34846667 in Environmental science and pollution research international as Journal Article, Review, with publication-date metadata of 2021-11-30 (day precision). PeptideScanner associated the retained record with the identity slug aviptadil. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-34846667-aviptadil:v1`
- Evidence domain: Literature metadata
- Date in source: 2022-07-16
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-34846667-aviptadil/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/aviptadil.json#pubmed-pmid-34846667-aviptadil-v1
- Content SHA-256: `d1f3928bc213e3b48a0b0b462d562fea2068561160f12b21ace4dbfad0e5d2ee`

### Claims and source pins

#### Headline

Anticipated pharmacological role of Aviptadil on COVID-19. ([`pubmed-observation-pmid-34846667-2022-07-16-2a576d255bd9`](#source-pubmed-observation-pmid-34846667-2022-07-16-2a576d255bd9))

#### Summary

PubMed lists PMID 34846667 in Environmental science and pollution research international as Journal Article, Review, with publication-date metadata of 2021-11-30 (day precision). PeptideScanner associated the retained record with the identity slug aviptadil. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-34846667-2022-07-16-2a576d255bd9`](#source-pubmed-observation-pmid-34846667-2022-07-16-2a576d255bd9))

#### Paragraph 1

PubMed lists PMID 34846667 in Environmental science and pollution research international as Journal Article, Review, with publication-date metadata of 2021-11-30 (day precision). PeptideScanner associated the retained record with the identity slug aviptadil. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-34846667-2022-07-16-2a576d255bd9`](#source-pubmed-observation-pmid-34846667-2022-07-16-2a576d255bd9))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-34846667-2022-07-16-2a576d255bd9`](#source-pubmed-observation-pmid-34846667-2022-07-16-2a576d255bd9))

### Sources

<a id="source-pubmed-observation-pmid-34846667-2022-07-16-2a576d255bd9"></a>
- **Anticipated pharmacological role of Aviptadil on COVID-19. · retained source version 1:2022-07-16:current:2a576d255bd90e5184469b212128a9903515107005dfa946141a7821ff4d2323** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/34846667/) (`pubmed-observation-pmid-34846667-2022-07-16-2a576d255bd9`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Anticipated pharmacological role of Aviptadil on COVID-19." Version 1, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/aviptadil.json#pubmed-pmid-34846667-aviptadil-v1 SHA-256: d1f3928bc213e3b48a0b0b462d562fea2068561160f12b21ace4dbfad0e5d2ee.

---

<a id="pubmed-pmid-35975856-aviptadil-v1"></a>

## Molecular Interactions of Zyesami with the SARS-CoV-2 nsp10/nsp16 Protein Complex.

> PubMed lists PMID 35975856 in Combinatorial chemistry & high throughput screening as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2023 (year precision). PeptideScanner associated the retained record with the identity slug aviptadil. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-35975856-aviptadil:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-01-27
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-35975856-aviptadil/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/aviptadil.json#pubmed-pmid-35975856-aviptadil-v1
- Content SHA-256: `b65fda3359a4b6fbbfa34c6c95c030c0652b43797b2088563ceaaf3b013405d6`

### Claims and source pins

#### Headline

Molecular Interactions of Zyesami with the SARS-CoV-2 nsp10/nsp16 Protein Complex. ([`pubmed-observation-pmid-35975856-2026-01-27-269c4318fbf8`](#source-pubmed-observation-pmid-35975856-2026-01-27-269c4318fbf8))

#### Summary

PubMed lists PMID 35975856 in Combinatorial chemistry & high throughput screening as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2023 (year precision). PeptideScanner associated the retained record with the identity slug aviptadil. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-35975856-2026-01-27-269c4318fbf8`](#source-pubmed-observation-pmid-35975856-2026-01-27-269c4318fbf8))

#### Paragraph 1

PubMed lists PMID 35975856 in Combinatorial chemistry & high throughput screening as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2023 (year precision). PeptideScanner associated the retained record with the identity slug aviptadil. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-35975856-2026-01-27-269c4318fbf8`](#source-pubmed-observation-pmid-35975856-2026-01-27-269c4318fbf8))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-35975856-2026-01-27-269c4318fbf8`](#source-pubmed-observation-pmid-35975856-2026-01-27-269c4318fbf8))

### Sources

<a id="source-pubmed-observation-pmid-35975856-2026-01-27-269c4318fbf8"></a>
- **Molecular Interactions of Zyesami with the SARS-CoV-2 nsp10/nsp16 Protein Complex. · retained source version 1:2026-01-27:current:269c4318fbf86d96114ec792e2702ed17142de2e5246f2cf81f2104d8c51627f** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/35975856/) (`pubmed-observation-pmid-35975856-2026-01-27-269c4318fbf8`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Molecular Interactions of Zyesami with the SARS-CoV-2 nsp10/nsp16 Protein Complex." Version 1, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/aviptadil.json#pubmed-pmid-35975856-aviptadil-v1 SHA-256: b65fda3359a4b6fbbfa34c6c95c030c0652b43797b2088563ceaaf3b013405d6.

---

<a id="pubmed-pmid-37774815-aviptadil-v1"></a>

## Peptiligase, an enzyme for efficient chemo-enzymatic synthesis of aviptadil.

> PubMed lists PMID 37774815 in International journal of biological macromolecules as Journal Article, with publication-date metadata of 2023-09-27 (day precision). PeptideScanner associated the retained record with the identity slug aviptadil. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-37774815-aviptadil:v1`
- Evidence domain: Literature metadata
- Date in source: 2023-11-27
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-37774815-aviptadil/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/aviptadil.json#pubmed-pmid-37774815-aviptadil-v1
- Content SHA-256: `c1e68fc3ca97dba1e333493d8daa346ef8aa6443dcec6ab4075bab3f9f05bbad`

### Claims and source pins

#### Headline

Peptiligase, an enzyme for efficient chemo-enzymatic synthesis of aviptadil. ([`pubmed-observation-pmid-37774815-2023-11-27-d5b4165a7e23`](#source-pubmed-observation-pmid-37774815-2023-11-27-d5b4165a7e23))

#### Summary

PubMed lists PMID 37774815 in International journal of biological macromolecules as Journal Article, with publication-date metadata of 2023-09-27 (day precision). PeptideScanner associated the retained record with the identity slug aviptadil. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-37774815-2023-11-27-d5b4165a7e23`](#source-pubmed-observation-pmid-37774815-2023-11-27-d5b4165a7e23))

#### Paragraph 1

PubMed lists PMID 37774815 in International journal of biological macromolecules as Journal Article, with publication-date metadata of 2023-09-27 (day precision). PeptideScanner associated the retained record with the identity slug aviptadil. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-37774815-2023-11-27-d5b4165a7e23`](#source-pubmed-observation-pmid-37774815-2023-11-27-d5b4165a7e23))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-37774815-2023-11-27-d5b4165a7e23`](#source-pubmed-observation-pmid-37774815-2023-11-27-d5b4165a7e23))

### Sources

<a id="source-pubmed-observation-pmid-37774815-2023-11-27-d5b4165a7e23"></a>
- **Peptiligase, an enzyme for efficient chemo-enzymatic synthesis of aviptadil. · retained source version 1:2023-11-27:current:d5b4165a7e2346f744644c6eb1f42169a03f6e99a730a6bb63ff23680c0d4d37** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/37774815/) (`pubmed-observation-pmid-37774815-2023-11-27-d5b4165a7e23`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Peptiligase, an enzyme for efficient chemo-enzymatic synthesis of aviptadil." Version 1, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/aviptadil.json#pubmed-pmid-37774815-aviptadil-v1 SHA-256: c1e68fc3ca97dba1e333493d8daa346ef8aa6443dcec6ab4075bab3f9f05bbad.

---

<a id="pubmed-pmid-41368449-aviptadil-v1"></a>

## Aviptadil Therapy in Acute Respiratory Distress Syndrome Patients: A Systematic Review and Meta-analysis.

> PubMed lists PMID 41368449 in Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine as Journal Article, Review, with publication-date metadata of 2025-11-18 (day precision). PeptideScanner associated the retained record with the identity slug aviptadil. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-41368449-aviptadil:v1`
- Evidence domain: Literature metadata
- Date in source: 2025-12-12
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-41368449-aviptadil/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/aviptadil.json#pubmed-pmid-41368449-aviptadil-v1
- Content SHA-256: `add5cebe77a8962f5e4e1d6f6e93bdb62d8e4788fe4a5ea83d6a41e35f91bfa1`

### Claims and source pins

#### Headline

Aviptadil Therapy in Acute Respiratory Distress Syndrome Patients: A Systematic Review and Meta-analysis. ([`pubmed-observation-pmid-41368449-2025-12-12-565bcb8cab84`](#source-pubmed-observation-pmid-41368449-2025-12-12-565bcb8cab84))

#### Summary

PubMed lists PMID 41368449 in Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine as Journal Article, Review, with publication-date metadata of 2025-11-18 (day precision). PeptideScanner associated the retained record with the identity slug aviptadil. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-41368449-2025-12-12-565bcb8cab84`](#source-pubmed-observation-pmid-41368449-2025-12-12-565bcb8cab84))

#### Paragraph 1

PubMed lists PMID 41368449 in Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine as Journal Article, Review, with publication-date metadata of 2025-11-18 (day precision). PeptideScanner associated the retained record with the identity slug aviptadil. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-41368449-2025-12-12-565bcb8cab84`](#source-pubmed-observation-pmid-41368449-2025-12-12-565bcb8cab84))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-41368449-2025-12-12-565bcb8cab84`](#source-pubmed-observation-pmid-41368449-2025-12-12-565bcb8cab84))

### Sources

<a id="source-pubmed-observation-pmid-41368449-2025-12-12-565bcb8cab84"></a>
- **Aviptadil Therapy in Acute Respiratory Distress Syndrome Patients: A Systematic Review and Meta-analysis. · retained source version 1:2025-12-12:current:565bcb8cab84478a825d366b7da982de62c958d4d6c544f4375a1c04c31b7a71** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/41368449/) (`pubmed-observation-pmid-41368449-2025-12-12-565bcb8cab84`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Aviptadil Therapy in Acute Respiratory Distress Syndrome Patients: A Systematic Review and Meta-analysis." Version 1, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/aviptadil.json#pubmed-pmid-41368449-aviptadil-v1 SHA-256: add5cebe77a8962f5e4e1d6f6e93bdb62d8e4788fe4a5ea83d6a41e35f91bfa1.

---

<a id="pubmed-pmid-41368453-aviptadil-v1"></a>

## Aviptadil in Acute Respiratory Distress Syndrome-Promise or Mirage?

> PubMed lists PMID 41368453 in Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine as Editorial, with publication-date metadata of 2025-11-18 (day precision). PeptideScanner associated the retained record with the identity slug aviptadil. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-41368453-aviptadil:v1`
- Evidence domain: Literature metadata
- Date in source: 2026-09-25
- Source checked: 2026-11-16
- Published by PeptideScanner: 2026-11-16
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-41368453-aviptadil/
- JSON record: https://peptidescanner.com/evidence/v1/peptides/aviptadil.json#pubmed-pmid-41368453-aviptadil-v1
- Content SHA-256: `3577bd4c82df284318cdaa0116e140eaa22b34d29032babaf7e1e3e93c01de52`

### Claims and source pins

#### Headline

Aviptadil in Acute Respiratory Distress Syndrome-Promise or Mirage? ([`pubmed-observation-pmid-41368453-2026-09-25-51285ccffe5c`](#source-pubmed-observation-pmid-41368453-2026-09-25-51285ccffe5c))

#### Summary

PubMed lists PMID 41368453 in Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine as Editorial, with publication-date metadata of 2025-11-18 (day precision). PeptideScanner associated the retained record with the identity slug aviptadil. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-41368453-2026-09-25-51285ccffe5c`](#source-pubmed-observation-pmid-41368453-2026-09-25-51285ccffe5c))

#### Paragraph 1

PubMed lists PMID 41368453 in Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine as Editorial, with publication-date metadata of 2025-11-18 (day precision). PeptideScanner associated the retained record with the identity slug aviptadil. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-41368453-2026-09-25-51285ccffe5c`](#source-pubmed-observation-pmid-41368453-2026-09-25-51285ccffe5c))

#### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-41368453-2026-09-25-51285ccffe5c`](#source-pubmed-observation-pmid-41368453-2026-09-25-51285ccffe5c))

### Sources

<a id="source-pubmed-observation-pmid-41368453-2026-09-25-51285ccffe5c"></a>
- **Aviptadil in Acute Respiratory Distress Syndrome-Promise or Mirage? · retained source version 1:2026-09-25:current:51285ccffe5cc5284044da4b58fc4fe80cd1b433d2a7b98f92192dbdeca71d29** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/41368453/) (`pubmed-observation-pmid-41368453-2026-09-25-51285ccffe5c`)

### Correction lineage

No correction is recorded for this version.

### Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

### Suggested citation

PeptideScanner. "Aviptadil in Acute Respiratory Distress Syndrome-Promise or Mirage?" Version 1, published 2026-11-16. https://peptidescanner.com/evidence/v1/peptides/aviptadil.json#pubmed-pmid-41368453-aviptadil-v1 SHA-256: 3577bd4c82df284318cdaa0116e140eaa22b34d29032babaf7e1e3e93c01de52.

